UBS Group’s Damora Therapeutics, Inc. Common Stock DMRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $147K | Buy |
|
|||||
|
2025
Q3 | $220 | Sell |
|
|||||
|
2025
Q2 | $7.89K | Buy |
|
|||||
|
2025
Q1 | $883 | Sell |
|
|||||
|
2024
Q4 | $58K | Buy |
|
|||||
|
2024
Q3 | $62K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $3.08K | Sell |
|
|||||
|
2023
Q3 | $5.1K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $4.94K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $8K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $5K | Sell |
|
|||||
|
2021
Q4 | $20K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $40K | Buy |
|